- 全部删除
您的购物车当前为空
PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) 是一种口服活性的 VEGFA mRNA 翻译抑制剂,可选择性地抑制转录后水平的 VEGF 蛋白合成。它还是二氢乳酸脱氢酶 (DHODH) 的有效抑制剂,可研究血液系统恶性肿瘤。


为众多的药物研发团队赋能,
让新药发现更简单!
PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) 是一种口服活性的 VEGFA mRNA 翻译抑制剂,可选择性地抑制转录后水平的 VEGF 蛋白合成。它还是二氢乳酸脱氢酶 (DHODH) 的有效抑制剂,可研究血液系统恶性肿瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 898 | In stock | |
| 5 mg | ¥ 2,530 | In stock | |
| 10 mg | ¥ 3,850 | In stock | |
| 25 mg | ¥ 6,190 | In stock | |
| 50 mg | ¥ 8,520 | In stock | |
| 100 mg | ¥ 11,300 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,590 | In stock |
PTC299 相关产品
| 产品描述 | PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) is an orally active inhibitor of VEGFA mRNA translation and selectively inhibits VEGF protein synthesis at the post-transcriptional level. PTC299 is also a potent inhibitor of dihydrolactate dehydrogenase (DHODH). |
| 体外活性 | PTC299 作为一种在表型筛选中发现的VEGFA mRNA翻译抑制剂,已在临床中评估用于治疗实体瘤。为引导精准癌症治疗,我们对PTC299的活性进行了深入的生物学特征分析,证明了PTC299通过靶向限速酶二氢乳酸脱氢酶 (DHODH) ——负责嘧啶核苷酸的新生合成—减少尿嘧啶核苷酸来抑制VEGF产生和细胞增殖。 |
| 别名 | Emvododstat, (4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate |
| 分子量 | 467.34 |
| 分子式 | C25H20Cl2N2O3 |
| CAS No. | 1256565-36-2 |
| Smiles | COc1ccc(cc1)[C@@H]1N(CCc2c1[nH]c1ccc(Cl)cc21)C(=O)Oc1ccc(Cl)cc1 |
| 密度 | 1.395 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (106.99 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容